Filter by country
Africa
Sao Tome and Principe
Liberia
Madagascar
Malawi
Mali
Mauritania
Mozambique
Niger
Nigeria
Rwanda
Lesotho
Senegal
Sierra Leone
South Sudan
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe
Cote d'Ivoire
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic (the)
Chad
Comoros (the)
Congo (the)
Angola
Congo, DR
Eritrea
Ethiopia
The Gambia
Ghana
Guinea-Bissau
Guinea
Kenya
South-East Asia
Bangladesh
Bhutan
China
Korea, DPR
India
Indonesia
Myanmar
Nepal
Sri Lanka
Timor Leste
Americas
Cuba
Haiti
Honduras
Nicaragua
Bolivia
Guyana
Europe
Albania
Armenia
Azerbaijan
Bosnia-Herzegovina
Georgia
Kyrgyzstan
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Western Pacific
Cambodia
Kiribati
Lao PDR
Mongolia
Papua New Guinea
Solomon Islands
Vietnam
Eastern Mediterranean
Afghanistan
Djibouti
Pakistan
Somalia
Sudan (the)
Yemen
Filter by Category
Documents
Gavi Process Guidelines
IRC reports
Portuguese
Annual Contributions and Proceeds
Cash Receipts
Advocacy
Resource mobilisation
German
COVID-19 situation report
COVAX documents
COVAX AMC
Russian
Gavi Programme Funding Guidelines
Programme audit
Internal audit
Investigation
Reports to the Board
Other (IA)
COVAX data brief
DHI
VIS
White papers
AMC Documents
Country Documents
Evaluations
Financial Reports
Guidelines and Forms
Legal
Strategy
Supply and Procurement
Policies
Annual Reports
Gavi Fact Sheets
Gavi Publications
The Evidence Base
Gavi Bulletin
Other Publishers
Board Minutes
Committee minutes
Audit
Spanish
News
AMC Updates
Gavi Features
Press Releases
Roi
Statements
Gavi Blogs
Vaccineswork
Theme - Pentavalent
Top stories
3rd donor pledging
3rd donor pledging featured
Partner news
IATI
Social media toolkit
Audio Visual
Infographics
Presentations
Videos
Galleries
Board
Committee
Members

Articles (4262)

Showing 12 of 4262 View All
Showing 128 of 356 pages

Can mRNA vaccine tech take on tuberculosis?

Clinical trials of an mRNA vaccine for TB are set to begin this year. TB kills around 1.5 million people a year, mostly in developing countries. Research funding remains a major obstacle to progress.

Wanted: A vaccine against the measles

How the measles virus was trapped and tamed in vaccinology’s wild West.

Vaccine reaches Nepal’s provinces just in time for typhoid season

Nepal’s government has kicked off a major typhoid conjugate vaccine (TCV) campaign, also introducing this lifesaving vaccine into the country’s routine immunisation programme.

People who’ve had COVID appear more likely to develop diabetes – here’s why that might be

A number of recent studies indicate people who have had COVID are more likely to be diagnosed with diabetes.

Stopping cholera before it can start: vaccines reach South Sudan’s flood-hit IDP camps

To pre-empt potential cholera outbreaks due to flooding, Unity State in South Sudan has vaccinated 200,000 people.

Tackling Cameroon’s worst cholera outbreak in decades

Health experts in Cameroon have called for vigilance and the respect of basic hygienic rules as the country grapples with a severe cholera outbreak.

WHO says just one dose of HPV vaccine protects against cervical cancer

Cervical cancer kills one woman every two minutes, but the need for two or three doses is a major reason why vaccine uptake has been slow – this finding should mean many more lives are saved through HPV vaccination.

Everything you need to know about COVID-19 antivirals

Several antiviral pills have now been authorised to treat COVID-19, but how do they work and will people in developing countries be able to access them?

India draws lessons from polio eradication initiative

The programme to eradicate polio shows that mass immunisation is possible in India.

Celebrating Nepal’s typhoid conjugate vaccine introduction

The introduction of typhoid conjugate vaccine in Nepal is a great step forward in keeping children healthy and protected from typhoid.

Europe at risk of measles resurgence as COVID-19 restrictions are eased

With many countries failing to hit measles vaccine coverage targets, and COVID-19 control measures being lifted, the goal of measles elimination hangs in the balance.

World leaders commit US$ 4.8 billion to help Break COVID Now

Summit sees US$ 4.8 billion in commitments, securing vital cash to help lower income countries boost vaccinations now, secure equitable access for new vaccine procurements plus additional help for countries looking to procure their own vaccines…

Subscribe to our newsletter